-
Loading metrics
Open Access
Peer-reviewed
Research Article
In Vitro and In Vivo Characterization of the Alkaloid Nuciferine
-
Martilias S. Farrell ,
* E-mail: martilias_farrell@med.unc.edu
Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
John D. McCorvy,
Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Xi-Ping Huang,
Affiliations Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Daniel J. Urban,
Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Kate L. White,
Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Patrick M. Giguere,
Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Allison K. Doak,
Affiliation Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America
⨯ -
Alison I. Bernstein,
Affiliation Department of Environmental Health, Rollins School of Public Health and Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, United States of America
⨯ -
Kristen A. Stout,
Affiliation Department of Environmental Health, Rollins School of Public Health and Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, United States of America
⨯ -
Su Mi Park,
Affiliation Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Ramona M. Rodriguiz,
Affiliation Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Bradley W. Gray,
Affiliation Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
William S. Hyatt,
Affiliation Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
Andrew P. Norwood,
Affiliation Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
Kevin A. Webster,
Affiliation Department of Psychology, Virginia Commonwealth University, Richmond, Virginia, United States of America
⨯ -
Brenda M. Gannon,
Affiliation Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
Gary W. Miller,
Affiliation Department of Environmental Health, Rollins School of Public Health and Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, United States of America
⨯ -
Joseph H. Porter,
Affiliation Department of Psychology, Virginia Commonwealth University, Richmond, Virginia, United States of America
⨯ -
Brian K. Shoichet,
Affiliation Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America
⨯ -
William E. Fantegrossi,
Affiliation Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
William C. Wetsel,
Affiliation Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina, United States of America
⨯ - [ ... ],
-
Bryan L. Roth
Affiliations Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Program in Neuroscience, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Division of Chemical Biology and Medicinal Chemistry, School of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ - [ view all ]
- [ view less ]
In Vitro and In Vivo Characterization of the Alkaloid Nuciferine
- Martilias S. Farrell,
- John D. McCorvy,
- Xi-Ping Huang,
- Daniel J. Urban,
- Kate L. White,
- Patrick M. Giguere,
- Allison K. Doak,
- Alison I. Bernstein,
- Kristen A. Stout,
- Su Mi Park
- Published: March 10, 2016
- https://doi.org/10.1371/journal.pone.0150602